Procalcitonin

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2020 English Publisher:Elsevier BVJournal:Critical Care Clinics, volume 36, pages 23-40 (issn: 0749-0704,

Copyright policy )

Authors: Bachar, Hamade; David T, Huang;

doi: 10.1016/j.ccc.2019.08.003

pmid: 31733680

pmc: PMC6866676

Procalcitonin

- Summary
- Subjects
- Metrics

Abstract

Procalcitonin is a biomarker that is generally elevated in bacterial infections. This review describes a conceptual framework for biomarkers using lessons from the history of troponin, applies this framework to procalcitonin with a review of observational studies and randomized trials in and out of the intensive care unit, and concludes with clinical recommendations and thoughts on how to test a test.

Related Organizations

University of Pittsburgh
United States
University of Pittsburgh Medical Center
United States
American University of Beirut Medical Center
Lebanon
Centers for New Horizons
United States

Keywords

Sepsis, Humans, Procalcitonin, Respiratory Tract Infections, Biomarkers, Anti-Bacterial Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	142
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 1%